NCT01673399View on ClinicalTrials.gov

Oxytocin Antagonist in Patients With Repeated Failure of Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Implantation Failure
Interventions
DRUG

Atosiban

Bolus atosiban 6.75mg + infusion atosiban 18mg/u during 3 hours. once administered starting 1 hour before embryotransfer.

DRUG

placebo

Trial Locations (1)

9000

AZ Jan Palfijn, Ghent

All Listed Sponsors
collaborator

Onze Lieve Vrouw Hospital

OTHER

lead

AZ Jan Palfijn Gent

OTHER

NCT01673399 - Oxytocin Antagonist in Patients With Repeated Failure of Implantation | Biotech Hunter | Biotech Hunter